References
- Lebovitz HE, Feingles MN. The oral hypoglycemic agents. In: Ellenberg M, Rifkin H. Diabetes mellitus: theory and practice. 3d ed. New Hyde Park, NY: Medical Examination Publishing, 1983: 591–610
- Olson OC. Diagnosis and management of diabetes mellitus. New York: Raven Press, 1988: 80
- Selected readings
- Bunn HF. Evaluation of glycosylated hemoglobin diabetic patients. Diabetes 1981: 30(7): 613–7
- The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 1987: 10(1): 1–19
- Felig PU, McCurdy DK. The hypertonic state. N Engl J Med 1977: 297(26): 1444–54
- Hollenbeck CB, Connor WE, Riddle MC, et al. The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus. Metabolism 1985: 34(6): 559–66
- Jarrett RJ. Is insulin atherogenic? Diabetologia 1988: 31(2): 71–5
- National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 28(12): 1039–57
- Olefsky JM, Reaven GM. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med 1976: 60(1): 89–95